Ye, L., Mei, C., Ren, Y., Zhou, X., Ma, L., Xu, W., . . . Tong, H. (2021). Lower-dose decitabine improves clinical response compared with best supportive care in lower-risk MDS patients: A prospective, multicenter phase 2 study. J Cancer.
Chicago ZitierstilYe, Li, et al. "Lower-dose Decitabine Improves Clinical Response Compared With Best Supportive Care in Lower-risk MDS Patients: A Prospective, Multicenter Phase 2 Study." J Cancer 2021.
MLA ZitierstilYe, Li, et al. "Lower-dose Decitabine Improves Clinical Response Compared With Best Supportive Care in Lower-risk MDS Patients: A Prospective, Multicenter Phase 2 Study." J Cancer 2021.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.